Form 4: RTW Investments Exercises Orchestra BioMed Warrants

RTW Investments, LP, through its affiliated funds, exercised pre-funded warrants for Orchestra BioMed Holdings, Inc. common stock, resulting in a net increase in beneficial ownership.

Summary

• RTW Investments, LP, acting through its managed funds (the "RTW Funds"), exercised pre-funded warrants to acquire 1,250,032 shares of Orchestra BioMed Holdings, Inc. common stock on April 27, 2026.
• The exercise was conducted on a cashless basis, where 32 shares were withheld to cover the exercise price of $0.0001 per share.
• This resulted in the issuance of 1,250,000 shares to the RTW Funds.
• Following the transaction, RTW Investments, LP, through the RTW Funds, beneficially owns 9,556,063 shares of common stock.
• The pre-funded warrants have no expiration date but are subject to a beneficial ownership limitation of 19.99% of the issuer's outstanding common stock.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a neutral to slightly positive filing, as it represents a significant investor exercising their rights, indicating continued belief in the company, but it is a standard disclosure without new operational or financial performance data.

Positives

• RTW Investments, LP, a significant holder, has increased its direct stake in Orchestra BioMed Holdings, Inc. by exercising warrants.
• The exercise of warrants indicates confidence in the company's future prospects by a major investor.
• The cashless exercise mechanism minimizes immediate cash outlay for the exercising entity.

Negatives

• The exercise resulted in the withholding of 32 shares to cover the exercise price, representing a minor reduction in the gross number of shares acquired.
• The beneficial ownership is indirect, held by affiliated funds managed by RTW Investments, LP, with Roderick Wong disclaiming beneficial ownership beyond his pecuniary interest.

Risks

• The exercise of pre-funded warrants is subject to a 19.99% ownership cap, preventing RTW Funds from exceeding this threshold of the issuer's outstanding common stock.
• Potential for future dilution if the company issues more shares, which could impact the percentage ownership of RTW Funds.

Future Outlook

The filing does not contain explicit forward-looking statements or guidance from the company. However, the exercise of warrants by a significant investor may imply a positive outlook from that investor's perspective.

Management Comments

• The Reporting Persons disclaim beneficial ownership of the reported securities for purposes of Section 16 under the Securities Exchange Act of 1934, as amended, except to the extent of their pecuniary interest therein.
• Roderick Wong, M.D. serves as the Managing Partner and Chief Investment Officer of RTW.

Industry Context

StockSavvy.ai notes that Form 4 filings are standard disclosures for significant beneficial ownership changes by insiders or major shareholders. The exercise of warrants by RTW Investments, a known healthcare-focused investment firm, in Orchestra BioMed, a company in the same sector, is a common event in the biotechnology and medical device industry, often signaling continued conviction in a portfolio company's development pipeline or strategic direction.

Stakeholder Impact

• Shareholders: The exercise of warrants by a major investor may be viewed positively, potentially signaling confidence, but it does not immediately change the company's fundamental value or operational performance.
• RTW Investments, LP: Increases its direct beneficial ownership and potential economic interest in Orchestra BioMed Holdings, Inc.
• Orchestra BioMed Holdings, Inc.: Receives a nominal amount of capital ($0.0001 per share exercised) and has a significant investor reaffirming its stake, though the primary impact is on ownership structure rather than immediate funding.

Next Steps

• RTW Investments, LP will continue to monitor its beneficial ownership percentage to ensure it does not exceed the 19.99% cap.
• Orchestra BioMed Holdings, Inc. will continue its operations and report future financial and operational results.

Key Dates

Keywords

Form 4, SEC Filing, RTW Investments, Orchestra BioMed Holdings, OBIO, Warrants, Pre-funded Warrants, Beneficial Ownership, Securities Exchange Act, Insider Trading